Skip to main content
. Author manuscript; available in PMC: 2012 Sep 11.
Published in final edited form as: Public Health Nutr. 2011 May 24;14(10):1714–1723. doi: 10.1017/S1368980011000796

Fig. 3.

Fig. 3

Prevalence odds ratio (POR) of high fibrinogen, high plasminogen activator inhibitor-1 (PAI-1) and high high-sensitivity C-reactive protein (hs-CRP) by BMI (Inline graphic), waist circumference (WC; Inline graphic), waist-to-hip ratio (WHR; Inline graphic) and waist-to-height ratio (WHtR; Inline graphic), adjusted by age and sex. POR (95 % CI) for high fibrinogen: WC (tertile 2, 1·22 (0·86, 1·73); tertile 3, 1·90 (1·33, 2·71)), WHtR (tertile 2, 1·17, 0·83, 1·66; tertile 3, 1·92 (1·34, 2·70)), BMI (tertile 2, 1·07, 0·76, 1·50; tertile 3, 1·62 (1·15, 2·29)) and WHR (tertile 2, 1·21, 0·85, 1·73; tertile 3, 1·42 (0·93, 2·16)). POR (95% CI) for high PAI-1: WHtR (tertile 2, 3·23 (2·22, 4·69); tertile 3, 6·85 (4·62, 10·17)), WC (tertile 2, 3·12 (2·14, 4·55); tertile 3, 6·62 (4·46, 9·82)), BMI (tertile 2, 2·91 (2·01, 4·21); tertile 3, 5·90 (4·04, 8·62)) and WHR (tertile 2, 1·99 (1·38, 2·86); tertile 3, 4·63 (2·95, 7·28)). POR (95 % CI) for high hs-CRP: WHtR (tertile 2, 2·78 (1·48, 5·24); tertile 3, 6·97 (3·86, 12·58)), WC (tertile 2, 2·07 (1·14, 3·57); tertile 3, 5·19 (3·06, 8·81)), WHR (tertile 2, 1·68 (1·02, 2·77); tertile 3, 2·54 (1·44, 4·49)) and BMI (tertile 2, 1·61 (0·89, 2·93); tertile 3, 4·43 (2·61, 7·51))